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1. Introduction
The prevalence of chronic kidney disease (CKD) is increasing [1]. This rise is probably attrib‐
utable to the progressively aging population and to the increased prevalence of comorbid
conditions namely obesity, diabetes, and hypertension. According to the data from the Na‐
tional Health and Nutrition Examination Surveys, the prevalence of CKD in participants 70
years old and older is 46.8% compared to 6.7% in those between 40–59 years of age [1].
Many patients with CKD are unlikely to exhibit sufficient progressive decline in renal func‐
tion to require renal replacement therapy (RRT), in fact according to the findings present in
literature only a small percentage of CKD patients ultimately require RRT [2-5]. In part, this
low rate is explained by the increased risk of death from cardiovascular causes before pro‐
gression to end-stage renal disease (ESRD) can occur [6]. In part, it is secondary to the earlier
referral than in the past to nephrologists with improvement of nondialytic maximum con‐
servative management (MCM) focused on quality of life and patient comfort (i.e. maximiz‐
ing renoprotective therapies, additional dietary interventions) [7,8]. In 2008, more than
110,000 Americans were started on maintenance RRT, a life-saving therapy for patients with
ESRD [6]. Ideally, when patients begin RRT they should meet the following conditions: first‐
ly, they should not require hospitalization for the management of untreated acute or chronic
complications of uraemia; secondly, they should have a thorough understanding of the dif‐
ferent treatment options; and thirdly, they should have a functioning, permanent access for
the RRT of their choice [9].
Unfortunately still a sizable proportion of patients in the USA are not adequately prepared
for starting RRT. In 2008, 44% of patients received no predialysis nephrology care and only
25% had received ongoing care by a nephrologist for more than 12 months prior to initiating
dialysis [6]. Despite the critical importance of lifestyle management fewer than 10% of pa‐
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tients receive dietary counselling prior to starting RRT [6]. Furthermore, many patients new‐
ly diagnosed with ESRD are not offered alternatives to RRT (such as home dialysis or pre-
emptive transplantation), even in the absence of medical contraindications [10,11]. More
than 80% of patients in the USA initiate RRT with a central venous catheter (CVC), a type of
access associated with significantly higher rates of infectious complications and of long-term
non-infectious complications compared with a permanent vascular access [6, 12-14]. Inade‐
quate preparation for RRT in the USA can only partially be accounted for delayed referral to
nephrologists; as a considerable number of patients who have received more than 1 year of
specialist care prior to initiating RRT are also inadequately prepared for this treatment [6].
In 2006, the annualized mortality in the first 3 months of starting RRT for patients in the
USA was approximately 45%, which was in part due to inadequate preparation and educa‐
tion [15]. The available data on RRT preparation practices outside the USA are limited but
seem highlight the same challenge, the need of a better selection and preparation to RRT
[16]. Analyses from the Dialysis Outcomes and Practice Patterns Study (DOPPS) and find‐
ings from studies conducted in the 1980s and 1990s indicate a high rate of delayed referrals
to a nephrologist in Europe, and contemporary data from Canada also demonstrate a high
incidence of suboptimal RRT initiation [1,16-19].
Although dialysis prolongs the lives of many individuals with ESRD, the burden of RRT might
not justify the potential benefits of treatment in certain patients, such as the elderly [20]. How‐
ever, as illustrated by the North Thames Dialysis Study and by one Canadian study, judgment
on the appropriateness for RRT should not depend solely upon chronological age but should in‐
stead be based on a composite assessment of the health and functional status of the individual
[21,22]. Results from other studies suggest that there are subgroups of patients who have a low
likelihood of benefiting from RRT [23-25]. For example, initiating RRT does not reverse the pro‐
gressive decline in functional status; instead this decline seemingly accelerates after RRT initia‐
tion [23]. For selected individuals with advanced CKD, nondialytic MCM might, therefore, be
superior to initiating RRT [24] this suggestion highlights the importance of considering the ap‐
propriateness of RRT for individuals with CKD early in the disease course. Assessment of dis‐
ease management requires shared decision-making between patients, their family members,
and the treating physicians [25]. Most of the data on the principles of management and out‐
comes of patients with advanced CKD who elect to have MCM are derived from the United
Kingdom [24,26,27]. In most of the published studies to date, the life expectancy of patients with
advanced CKD who choose MCM is shorter than that of patients with matching characteristics
who choose RRT; the median life expectancy of patients with ESRD who forgo RRT has been re‐
ported to range from 14 months to 23 months [24,26,27]. However, the primary goal of care in
patients who opt for MCM should be focused on symptom management to enhance quality of
life and ensure patient comfort [9].
2. How is the choice made between hemodialysis and peritoneal dialysis?
Global comparisons show interesting differences between countries in the proportion of pa‐
tients with ESRD treated by peritoneal dialysis and hemodialysis. The wide discrepancy be‐
tween countries such as UK [45% of patients treated by peritoneal dialysis), and its
Hemodialysis476
neighbour France, where only 10% are so treated, indicates strong non-medical influences
on the choice of dialysis modality [28].
Economic reasons: the reimbursement to the physicians and the dialysis facilities for the cost
of providing treatment varies widely around the world. There are also large differences be‐
tween the levels of payment for hemodialysis and peritoneal dialysis in many countries. For
example in French the facility is not reimbursed for peritoneal dialysis and the physicians
receive no fee. Conversely in countries such as Hong Kong, where dialysis is only available
in the private sector, more patients are treated by peritoneal dialysis than by hemodialysis,
as the former is less expensive. If the physician has a financial interest in the hemodialysis
facility, this may directly influence the decision on which modality of treatment to recom‐
mend.
Physician preference: there is a strong preference for hemodialysis among some influential
nephrologists on both sides of the Atlantic. This is supported by data from USRDS [29]. In a
large US-based survey reported in 1997, only 25% of patients remembered having peritoneal
dialysis discussed with them. In contrast 68% of patients on peritoneal dialysis had had dis‐
cussions on hemodialysis. Interestingly, a much greater proportion of patients on hemodial‐
ysis felt that the choice had been made by the medical team rather than by either themselves
or by joint decision [29].
Geography and sociocultural influences: home dialysis, peritoneal dialysis or hemodialysis,
is a much more attractive proposition if the alternative is a long journey to the dialysis facili‐
ty. For example in New Zealand, in 1990 only 58% of dialysis patients lived in cities with
dialysis facilities. As a result, 50% of patients received peritoneal dialysis and 32% home di‐
alysis. In countries, such as Japan, most patients prefer to receive their medical care in a hos‐
pital setting [27]. They feel that is not appropriate for treatment to be done in the home and
are often reluctant to take responsibility for delivering their own care, as a result only 6% of
Japanese dialysis patients are on continuous ambulatory peritoneal dialysis.
3. Medical indications for peritoneal dialysis and hemodialysis
The majority of patients with ESRD are suitable for treatment with either peritoneal dialysis
or hemodialysis. There are no completely reliable data comparing mortality or morbidity for
these treatments and it is difficult to envisage an ethically acceptable trial where patients are
allocated randomly to different dialysis modalities [30,31].
3.1. Contraindications to dialysis modalities
3.1.1. Peritoneal dialysis
There are few situations where there is a consensus that peritoneal dialysis is contraindicat‐
ed. The consensus panel of the NKKF-DOQI has agreed the following relative contraindica‐
tions to peritoneal dialysis [32]:
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• Fresh intra-abdominal foreign body (e.g. aortic graft, ventriculo-peritoneal shunt): pa‐
tients with prosthetic aortic grafts have been successfully treated with peritoneal dialysis.
Hemodialysis is usually used initially for up to 16 weeks to allow the graft to be covered
with epithelium and so avoid the risk of graft infection via peritoneal dialysate. However
this risk must be balanced against that of bacterial seeding from the patient’s hemodialy‐
sis access.
• Body size limitations and intolerance of intra-abdominal fluid volume: body size can be a
problem at both ends of spectrum. The effect of increased intra-abdominal pressure can
be particularly marked in patients with chronic respiratory disease, with low back pain
and with large polycystic kidneys. In general, it is hard to predict a patient’s tolerance of
intra-abdominal fluid and so these limitations usually appear after a patient has started
peritoneal dialysis.
• Bowel disease and other sources of infection: the presence of ischemic bowel disease, in‐
flammatory bowel disease or diverticulitis is likely to increase the incidence of peritonitis
due to organisms passing through the bowel wall into the peritoneum. Abdominal wall
infection may lead to peritonitis via the exit site and catheter tunnel.
• Severe malnutrition or morbid obesity: patients should ideally commence peritoneal dial‐
ysis in an adequate nutritional state. Severe malnutrition may lead to poor wound healing
and to leakage from the catheter tunnel. In addition peritoneal protein losses during dial‐
ysis may exacerbate hypoalbuminenia. At the other end of the spectrum it may prove dif‐
ficult to satisfactorily place a catheter through the abdominal wall in patients with morbid
obesity. Thereafter absorption of glucose from the dialysate may contribute to further
weight gain.
3.1.2. Hemodialysis
Contraindications to hemodialysis are few. Access to the circulation can usually be obtained
even in patients with extensive vascular disease or previous surgery. An aversion to needle
puncture of the arteriovenous (A-V) fistula is common in the early stages but can usually be
overcome by careful use of local anaesthetic and nursing encouragement. Some patients
with severe cardiac disease may not tolerate the shifts in volume and electrolytes that occur
during hemodialysis treatment. However, there are no objective measurements that will re‐
liably identify such patients. Severe coagulopathy may make management of anticoagula‐
tion for the extracorporeal circuit difficult.
4. Vascular access for hemodialysis: Surgical considerations
The maintenance of adequate, durable vascular access for hemodialysis is essential for the
wellbeing of the patient with ERSD. The provision of hemodialysis requires repetitive vas‐
cular access that can achieve a blood flow in excess of 350 mL/min. If vascular access cannot
be achieved for even short period of time the patient will die from uraemia. Hemodialysis is
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employed in chronic maintenance hemodialysis, acute renal failure and elimination of poi‐
sons from the body. For the provision of chronic maintenance hemodialysis the require‐
ments for vascular access are very different from those for acute hemodialysis.
5. Vascular access for acute hemodialysis
5.1. Dual-lumen cuffed catheters
The vascular access requirements for acute hemodialysis are best served by the use of dual
lumen, non-cuffed, temporary catheters. These catheters are made of a variety of materials
including polyurethane or polytetrafluoroethylene. These materials have the useful proper‐
ty that a room temperature they are rigid, which facilitates their insertion, but when in
place, they achieve body temperature and become much more flexible. Dialysis catheters are
most commonly placed in the femoral, subclavian or jugular vein. Each of these sites has ad‐
vantages and disadvantages depending on specific clinical circumstances. The femoral vein
is in most patients the easiest site to insert a catheter and is associated with the lowest risk of
life threatening complications. The major disadvantages of using the femoral vein are that
the patient must remain recumbent while the catheter is in place and the high rate of infec‐
tion if the catheter is left in place for more than 72 hours. It is preferable to use femoral cath‐
eters of 24 cm length as the recirculation in these catheters has been shown to be
considerably lower than in the shorter 15 cm catheters. For patients who require longer peri‐
ods of renal replacement (>72 hours and <3 weeks), a dialysis catheter placed in the jugular
vein is preferable. The acute complications associated with both jugular and subclavian line
insertion are similar. However subclavian line insertions are associated with the longer-term
complication of subclavian vein stenosis, thus compromising the use of ipsilateral limb for
long term vascular access. Catheters placed under aseptic conditions in either the jugular or
subclavian vein may be left in place for up to 3 weeks. Complications associated with sub‐
clavian or jugular catheters include pneumothorax and arterial or great vein puncture with
associated mediastinal, pleural or pericardial haemorrhage. The risk of great vein perfora‐
tion is probably greatest in patients who have previously had multiple line insertions and
have developed subclavian vein stenosis. Patients with a previously documented subclavian
vein stenosis should never have a temporary catheter inserted on that side. It is imperative
that a chest X ray is taken prior to the initiation of hemodialysis after either jugular or sub‐
clavian lines are inserted. This is to exclude the development of either a pneumothorax or
hemothorax and to confirm that the catheter is in a position compatible with the desired ves‐
sel. If there is any doubt that the tip of the catheter is within a great vein, a small amount of
contrast should be injected into the catheter under fluoroscopic control.
Although a far inferior choice for vascular access than a primary artero-venous (A-V) fistula
or polytetrafluoroethylene (PTFE) graft, dual-lumen cuffed catheters have assumed an im‐
portant role in the provision of vascular access for ESRD patients. Whenever possible some
form of vascular access other than a cuffed catheter should be sought for a patient who has a
Select Ion and Preparation of Patients for Dialysis
http://dx.doi.org/10.5772/52266
479
prognosis of more than 6 months. In our opinion the cuffed catheter is best used as a bridge
between failed access and the establishment of permanent access.
6. Permanent vascular access
There is no doubt that a pre-emptively placed forearm primary A-V fistula is the most effec‐
tive form of long-term vascular access for the uremic patient. It is important for physicians
caring for patients with renal insufficiency to begin making plans for the provision of renal
replacement therapy at an early stage and this usually begin when creatinine clearance is <
25 mL/min or serum creatinine> 4 mg/dL. Pre-emptive planning for the provision of vascu‐
lar access is certainly cost-effective; it avoids emergency placement of femoral or subclavian
catheters and also reduces hospital admissions for infection and temporary access failure.
7. Types of permanent vascular access
7.1. Primary fistula
In 1962 Cimino and Brescia described the technique of anastomosing the radial artery to the
adjacent veins [33]. This technique allowed repeated puncturing of veins for dialysis access.
The most frequent problem associated with A-V fistula is a failure to mature, as manifested
by early thrombosis or inadequate blood flow rates. For patients in whom it is not possible
to create a primary radio cephalic A-V fistula, an upper arm brachiocephalic fistula is a sec‐
ond best alternative and preferable to the use of a polytetrafluoroethylene (PTFE) graft. An
upper arm brachiocephalic fistula takes few weeks to mature. Up to 80% of primary A-V fis‐
tulae will be functioning 3 years after creation.
7.2. PTFE grafts
PTFE was introduced in 1976 as a material for vascular bypass grafts. Since that time this
material has become the mainstay for vascular access in dialysis when autologous A-V fistu‐
la is either technically impossible or has failed to mature. Using PTFE as a conduit, a fistula
is created between an upper limb artery and vein.
More than 80% of the vascular procedures performed in the US [34]. Recent studies have
demonstrated that the use of PTFE grafts is actually increasing rather than decreasing. These
discrepancies between the US and other parts of the world have been attributed to the in‐
creased age of the dialysis population in the US and the increased proportion of ESRD pa‐
tients with diabetes and with poor quality vessels that provide inadequate vascular access,
as well as to the surgical practices that have evolved. More than 40% of patients who present
ESRD in the US have not had vascular access created prior to the initiation of hemodialysis.
Studies looking at the survival of PTFE grafts have noted cumulative patency rates for PTFE
grafts of between 63-90% at 1 year and 50-77% at 2 years; fewer than 50% survive beyond
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the third year. Newly inserted PTFE grafts should not be needled for at least 14 days be‐
cause adhesions of the subcutaneous tunnel and graft has not yet occurred; potential bleed‐
ing into the graft tunnel and hematoma thereof may ruin the access site.
Prior to the creation of a new vascular access route, it is important to evaluate the patient for
possible central vein stenosis. Clinical clues that should raise suspicion include oedema in
the extremities, collateral vein development, differential size of the extremities, and current
or previous placement of a cardiac pacemaker. If any of these findings are present the pa‐
tient should undergo venography or duplex ultrasound. If venous stenosis is identified, it is
preferable to plan access for the contralateral side if possible, although we have had occa‐
sional success in performing angioplasty on proximal veins and then proceeding with A-V
fistula or PTFE graft insertion.
8. The importance of preparation for dialysis
Every patient would make an informed choice between peritoneal and hemodialysis after a
period of counselling and preparation, unfortunately RRT is frequently started in less than
ideal circumstances. Reports from both Europe and US clearly document the excess of mor‐
bidity and mortality associated with patients presenting late in ESRD and requiring RRT as
an emergency procedure [14,15]. In fact patients starting RRT as an emergency usually re‐
ceive hemodialysis and require a temporary CVC. Compared with non-emergency patients,
their length of hospital stay is significantly greater and during this time there is a higher in‐
cidence of major complications and death. Data from USRD report [1997] showed that 25%
of hemodialysis and 16% of peritoneal dialysis patients stated that a nephrologist first saw
them less than one month before starting RRT; many of these patients would not have
sought any medical attention prior to their presentation but it is clearly important that GPs
promptly refer these patients for a specialist opinion.
Predialysis care by the nephrologist is focused on preventing or treating complications of
CKD, preserving residual renal function, ensuring that the patient has sufficient under‐
standing of his condition to chose between different RRT, and then arranging for appropri‐
ate access to be created in time before dialysis is required. In addition to the nephrologist
giving advice, further benefits may be gained if patients are offered a multidisciplinary edu‐
cational program.
Although few clinical trials have been conducted, there is enough evidence of clear benefits
of CKD education [35-41]. Early patient education is highly effective when focused on health
promotion, shared decision-making and discussion of treatment options [36]. In one
randomized, controlled trial on patient education, a one-on-one educational session fol‐
lowed by phone calls every 3 weeks significantly extended the time to requiring dialysis
[38]. Post hoc analyses from this clinical trial, as well as findings from other observational
studies, demonstrate a variety of additional benefits from patient education, including the
following: reduced patient anxiety; reduced number of hospitalizations; reduced numbers of
emergency room and physician visits; increased likelihood that the patient will remain em‐
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ployed in work and be more adherent to therapy; and reduced mortality [37,39,40]. Further‐
more, results from several studies have demonstrated a substantially reduced need for
CVCs following patient education [40,41]. Consequently, it is important to maximize these
benefits by engaging patients in CKD education prior to planning dialysis access placement.
Patient education involves messengers, messages, receivers and a process. Before patient ed‐
ucation can begin, the physician must initiate the discussion of what is often called breaking
the bad news [42,43]. Patients do not want insensitive truth telling but prefer for the truth to
be told with support to assist them in decision-making [44]. It is estimated that it takes an
average of five encounters before individuals actually understand the message; therefore,
patient education on CKD should be iterative [45]. The initial message should be delivered
in a private room that is free of interruptions, and preferably when the patient has a suppor‐
tive friend or relative with them [45]. Components of successful CKD education programs
have also included individualized and ongoing education throughout the course of the dis‐
ease, tours of dialysis facilities, meeting patients who are undergoing treatment with differ‐
ent dialysis modalities, use of videos and written materials, and behaviour changing
protocols with small group problem-solving activities [37,46,47]. These and other strategies
can be incorporated into any CKD education program. The educator needs to possess skills
in patient communication and to understand the nature of the patient’s barriers to receiving
the information.
Presenting treatment options to the patient is a major undertaking for the educator, and of‐
fering decision support is an important goal of successful CKD education. There is a large
variability in the uptake of home dialysis options (peritoneal dialysis or hemodialysis) be‐
tween centres, regions, and different countries [6]. Data from the USA indicate that the low
uptake of peritoneal dialysis in the country does not reflect patient choice but is instead
more often a reflection of the choice not being offered to patients by healthcare providers
[10,11]. Results from recent studies indicate that the 5-year and 10-year survival rates of pa‐
tients treated with in centre hemodialysis are equivalent to survival rates with peritoneal di‐
alysis [48]. Accordingly, for the vast majority of patients with CKD, decisions about dialysis
modality should be based on what fits best with their lifestyle a decision that patients and
their families must make for themselves [49]. Widespread, comprehensive CKD education
will also empower patients to assume responsibility for their dialysis care, thereby increas‐
ing the uptake of home dialysis options. Expansion of home dialysis therapy is likely to be
safe as the equivalency of outcomes of home peritoneal dialysis with in centre hemodialysis
are maintained even when much larger proportions of patients are treated with the former
therapy [48]. This therapy is also potentially more cost-effective given the lower societal
costs for providing peritoneal dialysis, compared with in centre hemodialysis, in many
countries[50].
The discussion about treatment options should begin with open questions and can be fol‐
lowed by introducing the two choices available to patients, dialysis or MCM. If the patient’s
preference is for dialysis, the choice of home dialysis versus in centre dialysis should be dis‐
cussed next. Notably, fear and/or lack of knowledge of home dialysis has been shown to dis‐
suade many patients from selecting this option [51]. One of the goals of patient education
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should be to offer patient support and help overcome such fear. Regular contact between the
educator and the patient over the weeks to months after starting education is important in
the process of decision-making. However, it is should be noted that the patient’s choice of
dialysis modality is simply the treatment with which they begin RRT, as many patients will
actually transition between different therapies (for example, changing dialysis modalities, or
from dialysis to transplantation and possibly back to dialysis again).
9. When RRT should be started?
In the 1990s, expert groups recommended that initiation of dialysis be considered when re‐
nal function declines to a predetermined level (mean of urea and creatinine clearance of
≤10.5 ml/min/1.73 m2] [52]. Over the past years, however, the mean estimated Glomerular
Filtration Rate (eGFR) of patients starting dialysis in the USA has progressively increased
[6,53]. Notwithstanding this change over time, there is no relationship between the duration
of pre- dialysis nephrology care and eGFR at the time of starting dialysis [54]. Furthermore,
patients who start dialysis with a high eGFR are as likely as patients with a lower eGFR to
use CVCs as the first dialysis access [54]. These observations suggest that nephrologists
might be recommending patients for dialysis for the same general reasons, irrespective of
eGFR. For example, individuals with low levels of serum creatinine (and a high eGFR)
might need to start dialysis if they are likely to have poor tolerance for the consequences of
renal function decline. Findings from several observational studies demonstrate that pa‐
tients who start dialysis with a high eGFR are substantially more likely to have characteris‐
tics associated with an increased mortality (such as older age, male sex, white ethnicity,
diabetes mellitus and other cardiovascular comorbidities). Concerns about the rising trend
of starting RRT in patients with a high eGFR have been raised, particularly since many stud‐
ies now show a direct association between a high eGFR at the time of RRT initiation and
subsequent risk of death [54-64]. This risk persists even after statistical adjustment for poten‐
tial confounders and also when analyses are restricted to the healthiest subgroup; however,
there is always the issue of residual confounding in observational studies [57,58]. Further‐
more, with decreasing renal function, muscle mass becomes a more important determinant
of serum creatinine level than is eGFR [65]. It follows then that the association between high
eGFR and an increased risk of death might, in part, be a reflection of the effect of cachexia
(muscle loss causing lower levels of serum creatinine at any given level of eGFR) on mortali‐
ty [56]. Given the limitations of observational studies, it is fortuitous that the importance of
renal function at RRT initiation has been tested in a randomized controlled clinical trial. In
the IDEAL study, there was no difference in terms of survival between patients randomly
assigned to begin dialysis early (at a creatinine clearance of 10–14 ml/min) or late (at a creati‐
nine clearance of 5–7 ml/min) [66]. It is important to note that three-quarters of patients ran‐
domly assigned to starting dialysis late actually needed to begin treatment earlier, primarily
owing to the development of uremic symptoms [66]. These data suggest that initiation of di‐
alysis simply when renal function approaches a predetermined threshold, as measured by
eGFR, is not appropriate. Indeed, it seems that dialysis can be safely delayed in otherwise
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asymptomatic individuals with advanced CKD. This is particularly important in patients in
whom a permanent dialysis access is not ready for use, and deferring dialysis might miti‐
gate the need for CVCs. However, findings from the IDEAL study also indicate that it might
not be universally possible to defer initiation of dialysis until patients reach an eGFR<7
ml/min/1.73 m2 as many patients with advanced CKD can develop uremic symptoms at
high levels of renal function [66]. In addition to the indications for emergent dialysis (hyper‐
kalaemia, volume overload, pericarditis and encephalopathy), dialysis therapy has been
shown to be effective in ameliorating uremic anorexia and is associated with improvement
in measures of protein energy wasting [67]. Hence, it is important to observe patients with
advanced CKD for the early development of symptoms and/or uremic complications and
begin dialysis at an appropriate time such that it precludes the development of complica‐
tions that might require hospitalization or emergency intervention.
10. Conclusions
It is extremely important to ensure that the resources dedicated to ESRD treatment are used
to best effect. If the greatest benefit is to be gained from RRT, the importance of selection
and preparation of patients reaching ESRD must be recognised and addressed. Educating
these individuals about CKD might, nevertheless, facilitate their participation in selection of
RRT modality and might also result in an earlier transition to a permanent RRT. Several
studies show that those measures lead to a reduction of the proportion of patients who start
RRT as an emergency procedure (higher incidence of major complications and death) [14,15]
and to an increasing number of patients that actively participate in developing their care
plan and who start dialysis with a permanent access [68,69].
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